Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Revenue | ||||||
| Revenue | $ 67,878 | $ 55,257 | $ 183,919 | $ 156,297 | $ 213,760 | $ 169,152 |
| Cost of revenue | ||||||
| Cost of revenue | 34,964 | 25,528 | 88,675 | 70,515 | 97,930 | 63,665 |
| Operating expenses | ||||||
| Selling, general and administrative | 26,001 | 17,792 | 66,525 | 49,907 | 72,883 | 65,298 |
| Depreciation and amortization | 12,440 | 13,176 | 37,947 | 38,884 | 52,488 | 48,131 |
| Intangible asset impairment loss | 3,892 | |||||
| Total operating expenses | 38,441 | 30,968 | 104,472 | 88,791 | 125,371 | 117,321 |
| Operating loss | (5,527) | (1,239) | (9,228) | (3,009) | (9,541) | (11,834) |
| Interest expense, including amortization of deferred financing costs, net | 5,589 | 5,276 | 16,155 | 18,359 | 23,493 | 24,785 |
| Change in fair value of warrant liability | (2,898) | 651 | (5,281) | 3,482 | 7,485 | (235) |
| Change in fair value of warrant liability | (7,485) | 235 | ||||
| Loss before income taxes | (8,218) | (7,166) | (20,102) | (24,850) | (40,519) | (36,384) |
| Income tax provision (benefit) | ||||||
| Current | 179 | 201 | 569 | 711 | 1,051 | (1,450) |
| Deferred | (3,889) | (1,719) | (8,197) | (6,087) | (6,369) | (11,491) |
| Total income tax benefit | (3,710) | (1,518) | (7,628) | (5,376) | (5,318) | (12,941) |
| Net loss | $ (4,508) | $ (5,648) | $ (12,474) | $ (19,474) | $ (35,201) | $ (23,443) |
| Loss per share: | ||||||
| Basic | $ (0.27) | $ (0.42) | $ (1.03) | $ (1.32) | $ (1.96) | $ (1.45) |
| Diluted | $ (0.27) | $ (0.42) | $ (1.03) | $ (1.32) | $ (1.96) | $ (1.45) |
| Weighted average shares outstanding (in Number): | ||||||
| Basic | 30,732,921 | 30,281,520 | 30,433,641 | 30,285,684 | 31,650,173 | 31,169,435 |
| Diluted | 30,732,921 | 30,281,520 | 30,433,641 | 30,285,684 | 31,650,173 | 31,169,435 |
| Service [Member] | ||||||
| Revenue | ||||||
| Revenue | $ 48,428 | $ 43,436 | $ 139,866 | $ 127,113 | $ 172,845 | $ 159,425 |
| Cost of revenue | ||||||
| Cost of revenue | 17,379 | 15,675 | 51,417 | 47,594 | 64,520 | 57,621 |
| Product [Member] | ||||||
| Revenue | ||||||
| Revenue | 19,450 | 11,821 | 44,053 | 29,184 | 40,915 | 9,727 |
| Cost of revenue | ||||||
| Cost of revenue | $ 17,585 | $ 9,853 | $ 37,258 | $ 22,921 | $ 33,410 | $ 6,044 |
| X | ||||||||||
- Definition Change in fair value of warrant liability No definition available.
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|